SEC (Securities and Exchange Commission) warns Lumenis over likely legal action
This article was originally published in Clinica
Executive Summary
The US Securities and Exchange Commission (SEC) has sent Yokneam, Israel-based Lumenis a Wells Notice, indicating that it may be preparing civil proceedings against the laser therapy firm. The move comes as part of an investigation by the SEC's Boston district office into Lumenis's accounts. Lumenis will now have time to discuss the issues with the SEC before the latter decides what action to take.